{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T19:55:17Z","timestamp":1718913317776},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2000,9,1]],"date-time":"2000-09-01T00:00:00Z","timestamp":967766400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2000,9]]},"DOI":"10.1007\/s11883-000-0078-0","type":"journal-article","created":{"date-parts":[[2007,5,22]],"date-time":"2007-05-22T21:55:18Z","timestamp":1179870918000},"page":"397-404","source":"Crossref","is-referenced-by-count":11,"title":["Insulin resistance in human partial lipodystrophy"],"prefix":"10.1007","volume":"2","author":[{"given":"Robert A.","family":"Hegele","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"78_CR1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1152\/physrev.1995.75.3.473","volume":"75","author":"GM Reaven","year":"1995","unstructured":"Reaven GM: Pathophysiology of insulin resistance in human disease. Physiol Rev 1995, 75:473\u2013486.","journal-title":"Physiol Rev"},{"key":"78_CR2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1515\/JBCPP.1998.9.2-4.387","volume":"9","author":"GM Reaven","year":"1998","unstructured":"Reaven GM: Insulin resistance and human disease: a short history. J Basic Clin Physiol Pharmacol 1998, 9:387\u2013406.","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"78_CR3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1126\/science.3513311","volume":"232","author":"MS Brown","year":"1986","unstructured":"Brown MS, Goldstein JL: A receptor-mediated pathway for cholesterol homeostasis. Science 1986, 232:34\u201347.","journal-title":"Science"},{"key":"78_CR4","first-page":"1383","volume":"334","author":"4S Investigators","year":"1994","unstructured":"4S Investigators: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994, 334:1383\u20131389.","journal-title":"Lancet"},{"key":"78_CR5","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0140-6736(46)90528-4","volume":"I","author":"RD Lawrence","year":"1946","unstructured":"Lawrence RD: Lipodystrophy and hepatomegaly with diabetes, lipaemia, and other metabolic disturbances: a case throwing new light on the action of insulin. Lancet 1946, I: 724\u2013731.","journal-title":"Lancet"},{"key":"78_CR6","first-page":"533","volume":"21","author":"FL Ozer","year":"1973","unstructured":"Ozer FL, Lichtenstein JR, Kwiterovich PO, McKusick VA: A new genetic variety of lipodystrophy. Clin Res 1973, 21:533.","journal-title":"Clin Res"},{"key":"78_CR7","first-page":"33","volume":"43","author":"MG Dunnigan","year":"1974","unstructured":"Dunnigan MG, Cochrane M, Kelly A, Scott JW: Familial lipoatrophic diabetes with dominant transmission: a new syndrome. Quart J Med 1974, 43:33\u201348.","journal-title":"Quart J Med"},{"key":"78_CR8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/jmg.23.2.120","volume":"23","author":"J Kobberling","year":"1986","unstructured":"Kobberling J, Dunnigan MG: Familial partial lipodystrophy: two types of an X linked dominant syndrome, lethal in the hemizygous state. J Med Genet 1986, 23:120\u2013127.","journal-title":"J Med Genet"},{"key":"78_CR9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/jmg.23.2.128","volume":"23","author":"J Burn","year":"1986","unstructured":"Burn J, Baraitser M: Partial lipoatrophy with insulin resistant diabetes and hyperlipidaemia (Dunnigan syndrome). J Med Genet 1986, 23:128\u2013130.","journal-title":"J Med Genet"},{"key":"78_CR10","first-page":"170","volume":"84","author":"A Garg","year":"1999","unstructured":"Garg A, Peshock RM, Fleckenstein JL: Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan variety). J Clin Endocrinol Metab 1999, 84:170\u2013174.","journal-title":"J Clin Endocrinol Metab"},{"key":"78_CR11","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/ng0398-292","volume":"18","author":"JM Peters","year":"1998","unstructured":"Peters JM, Barnes R, Bennett L, et al.: Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21-22. Nat Genet 1998, 18:292\u2013295.","journal-title":"Nat Genet"},{"key":"78_CR12","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1086\/301971","volume":"63","author":"SNJ Jackson","year":"1998","unstructured":"Jackson SNJ, Pinkney J, Bargiotta A, et al.: A defect in the regional deposition of adipose tissue (partial lipodystrophy) is encoded by a gene at chromosome 1q. Am J Hum Genet 1998, 63:534\u2013540.","journal-title":"Am J Hum Genet"},{"key":"78_CR13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/(SICI)1096-8628(19990115)82:2<161::AID-AJMG12>3.0.CO;2-0","volume":"82","author":"JL Anderson","year":"1999","unstructured":"Anderson JL, Khan M, David WS, et al.: Confirmation of linkage of hereditary partial lipodystrophy to chromosome 1q21-22. Am J Med Genet 1999, 82:161\u2013165.","journal-title":"Am J Med Genet"},{"key":"78_CR14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s100380050018","volume":"45","author":"H Cao","year":"2000","unstructured":"Cao H, Hegele RA: Human aryl hydrocarbon receptor nuclear translocator gene (ARNT) D\/N511 polymorphism. J Hum Genet 2000, 45:92\u201393.","journal-title":"J Hum Genet"},{"key":"78_CR15","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s100380050019","volume":"45","author":"H Cao","year":"2000","unstructured":"Cao H, Hegele RA: Human cathepsin S gene (CTSS) promoter \u221225G\/A polymorphism. J Hum Genet 2000: 45:94\u201395.","journal-title":"J Hum Genet"},{"key":"78_CR16","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s100380050022","volume":"45","author":"H Cao","year":"2000","unstructured":"Cao H, Hegele RA: Human C-reactive protein (CRP) 1059G\/C polymorphism. J Hum Genet 2000, 45:100\u2013101.","journal-title":"J Hum Genet"},{"key":"78_CR17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/jsbi.1998.3987","volume":"122","author":"N Stuurman","year":"1998","unstructured":"Stuurman N, Heins S, Aebi U: Nuclear lamins: their structure, assembly and interactions. J Struct Biol 1998, 122:42\u201366.","journal-title":"J Struct Biol"},{"key":"78_CR18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/6799","volume":"21","author":"G Bonne","year":"1999","unstructured":"Bonne G, DiBarletta MR, Varnous S, et al.: Mutations in the gene encoding lamin A\/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet 1999, 21:285\u2013288.","journal-title":"Nat Genet"},{"key":"78_CR19","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJM199912023412302","volume":"341","author":"D Fatkin","year":"1999","unstructured":"Fatkin D, MacRae C, Sasaki T, et al.: Missense mutations in the rod domain of the lamin A\/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 1999, 341:1715\u20131724.","journal-title":"N Engl J Med"},{"key":"78_CR20","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/hmg\/9.9.1453","volume":"9","author":"A Muchir","year":"2000","unstructured":"Muchir A, Bonne G, van der Kooi AJ, et al.: Identification of mutations in the gene encoding lamins A\/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum Mol Genet 2000, 9:1453\u20131459.","journal-title":"Hum Mol Genet"},{"key":"78_CR21","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/hmg\/9.1.109","volume":"9","author":"H Cao","year":"2000","unstructured":"Cao H, Hegele RA: Nuclear lamin A\/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum Mol Genet 2000, 9:109\u2013112.","journal-title":"Hum Mol Genet"},{"key":"78_CR22","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2337\/diacare.23.2.258","volume":"23","author":"RA Hegele","year":"2000","unstructured":"Hegele RA, Anderson CM, Cao H: Lamin A\/C mutation in a woman and her two daughters with Dunnigan-type partial lipodystrophy. Diabetes Care 2000, 23:258\u2013259.","journal-title":"Diabetes Care"},{"key":"78_CR23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/72807","volume":"24","author":"S Shackleton","year":"2000","unstructured":"Shackleton S, Lloyd DJ, Jackson SN, et al.: LMNA, encoding lamin A\/C, is mutated in partial lipodystrophy. Nat Genet 2000, 24:153\u2013156.","journal-title":"Nat Genet"},{"key":"78_CR24","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1086\/302836","volume":"66","author":"RA Speckman","year":"2000","unstructured":"Speckman RA, Garg A, Du F, et al.: Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A\/C. Am J Hum Genet 2000, 66:1192\u20131198.","journal-title":"Am J Hum Genet"},{"key":"78_CR25","doi-asserted-by":"crossref","unstructured":"Hegele RA, Cao H, Anderson CM, Hramiak I: Heterogeneity of nuclear lamin A mutations in Dunnigan-type familial partial lipodystrophy. J Clin Endo Metab 2000, in press.","DOI":"10.1210\/jc.85.9.3431"},{"key":"78_CR26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/(SICI)1098-1004(1997)9:2<97::AID-HUMU1>3.0.CO;2-M","volume":"9","author":"C Eng","year":"1997","unstructured":"Eng C, Mulligan LM: Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and hirschsprung disease. Hum Mutat 1997, 9:97\u2013109.","journal-title":"Hum Mutat"},{"key":"78_CR27","doi-asserted-by":"crossref","first-page":"6450","DOI":"10.1073\/pnas.83.17.6450","volume":"83","author":"DZ Fisher","year":"1986","unstructured":"Fisher DZ, Chaudhary N, Blobel G: cDNA sequencing of nuclear lamins A and C reveals primary and secondary structural homology to intermediate filament proteins. Proc Natl Acad Sci (USA) 1986, 83:6450\u20136454.","journal-title":"Proc Natl Acad Sci (USA)"},{"key":"78_CR28","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1093\/hmg\/8.10.1847","volume":"8","author":"GE Morris","year":"1999","unstructured":"Morris GE, Manilal S: Heart to heart: from nuclear proteins to Emery-Dreifuss muscular dystrophy. Hum Mol Genet 1999, 8:1847\u20131851.","journal-title":"Hum Mol Genet"},{"key":"78_CR29","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/72221","volume":"6","author":"RA Hegele","year":"2000","unstructured":"Hegele RA: The envelope, please: nuclear lamins and disease. Nat Med 2000, 6:136\u2013137.","journal-title":"Nat Med"},{"key":"78_CR30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/43448","volume":"401","author":"I Shimomura","year":"1999","unstructured":"Shimomura I, Hammer RE, Ikemoto S, et al.: Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 1999, 401:73\u201376.","journal-title":"Nature"},{"key":"78_CR31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/72734","volume":"24","author":"JS Flier","year":"2000","unstructured":"Flier JS: Pushing the envelope on lipodystrophy. Nat Genet 2000, 24:103\u2013104.","journal-title":"Nat Genet"},{"key":"78_CR32","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1101\/gr.10.5.652","volume":"10","author":"RA Hegele","year":"2000","unstructured":"Hegele RA, Anderson CM, Wang J, et al.: Association between nuclear lamin A\/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension and diabetes. Genome Res 2000, 10:652\u2013658.","journal-title":"Genome Res"},{"key":"78_CR33","doi-asserted-by":"crossref","unstructured":"Hegele RA, Cao CM, Huff MW, Anderson CM: LMNA R482Q mutation in partial lipodystrophy associated with reduced plasma leptin concentration. J Clin Endo Metab 2000, in press.","DOI":"10.1210\/jc.85.9.3089"},{"key":"78_CR34","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1073\/pnas.96.5.2327","volume":"96","author":"RH Unger","year":"1999","unstructured":"Unger RH, Zhou YT, Orci L: Regulation of fatty acid homeostasis in cells: novel role of leptin. Proc Natl Acad Sci USA 1999, 96:2327\u20132332.","journal-title":"Proc Natl Acad Sci USA"},{"key":"78_CR35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/(SICI)1099-0895(199812)14:4<263::AID-DMR233>3.0.CO;2-C","volume":"14","author":"PJ Randle","year":"1998","unstructured":"Randle PJ: Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab Rev 1998, 14:263\u2013283.","journal-title":"Diabetes Metab Rev"},{"issue":"1A","key":"78_CR36","doi-asserted-by":"crossref","first-page":"3J","DOI":"10.1016\/S0002-9149(99)00350-1","volume":"84","author":"GI Shulman","year":"1999","unstructured":"Shulman GI: Cellular mechanisms of insulin resistance in humans. Am J Cardiol 1999, 84(1A):3J-10J.","journal-title":"Am J Cardiol"},{"key":"78_CR37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1172\/JCI7901","volume":"105","author":"O Gavrilova","year":"2000","unstructured":"Gavrilova O, Marcus-Samuels B, Graham D, et al.: Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest 2000, 105:271\u2013278.","journal-title":"J Clin Invest"},{"key":"78_CR38","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1152\/physiolgenomics.2000.3.1.39","volume":"3","author":"RA Hegele","year":"2000","unstructured":"Hegele RA, Cao H, Harris SB, et al.: Genetic variation in LMNA modulates plasma leptin and indices of obesity in aboriginal Canadians. Physiological Genomics 2000, 3:39\u201344.","journal-title":"Physiological Genomics"},{"key":"78_CR39","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00019501-199809080-00002","volume":"9","author":"B Lamarche","year":"1998","unstructured":"Lamarche B: Abdominal obesity and its metabolic complications: implications for the risk of ischaemic heart disease. Coron Artery Dis 1998, 9:473\u2013481.","journal-title":"Coron Artery Dis"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-000-0078-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11883-000-0078-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-000-0078-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:42:43Z","timestamp":1559432563000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11883-000-0078-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["78"],"URL":"https:\/\/doi.org\/10.1007\/s11883-000-0078-0","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,9]]}}}